Randomized phase III trial of paclitaxel/carboplatin with or without PF-3512676 (toll-like receptor 9 agonist) as first-line treatment for advanced non-small-cell lung cancer

1. Hirsh, V.
2. Paz-Ares, L.
3. Boyer, M.
4. Rosell, R.
5. Middleton, G.
6. Eberhardt, W.E.E.
7. Szczesna, A.
8. Reiterer, P.
9. Saleh, M.
10. Arrieta, O.
11. Bajetta, E.
12. Webb, R.T.
13. Raats, J.
14. Benner, R.J.
15. Fowst, C.
16. Meech, S.J.
17. Readett, D.
18. Schiller, J.H.